ETV6 and acute lymphoblastic leukemia: GATA2 expression was also examined in the pediatric ALL cohort, which showed the ETV6/RUNX1-positive group had an average Ct difference of 4.79, representing 27.67-fold higher expression (p < 0.001), Figure 2C.